Brivekimig (F-027300252) is a bispecific nanobody against TNF and OX40L. Brivekimig exhibits immunomodulatory activity and can be used in the research of diseases such as hidradenitis suppurativa[1][2].
Molecular Weight:
(66.21 kDa)
Purity:
98
CAS Number:
[2834733-45-6]
Target:
TNF Receptor
Application Notes:
MCE Product type: Inhibitory Antibodies
* VAT and and shipping costs not included. Errors and price changes excepted